Showing 1 - 10 of 3,073
Distribution of goods has evolved in two main directions that seem contradictory : on the one hand, the mass distribution was fully developed in terms of distribution facilities, logistics, comfort, and standardization of goods and services, on the other hand, the increased competition and...
Persistent link: https://www.econbiz.de/10010797544
Distribution of goods has evolved in two main directions that seem contradictory : on the one hand, the mass distribution was fully developed in terms of distribution facilities, logistics, comfort, and standardization of goods and services, on the other hand, the increased competition and...
Persistent link: https://www.econbiz.de/10010682831
Distribution of goods has evolved in two main directions that seem contradictory : on the one hand, the mass distribution was fully developed in terms of distribution facilities, logistics, comfort, and standardization of goods and services, on the other hand, the increased competition and...
Persistent link: https://www.econbiz.de/10011079752
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10008693155
Indian pharmaceutical industry is one of the fastest growing sectors of Indian economy but the medicines we take suffer from serious ills: they are not stored and transported the way they ought to be. Pharmaceutical companies face issues related to choosing and working with the right logistics...
Persistent link: https://www.econbiz.de/10010668805
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the industry has three strong pillars: very pro active...
Persistent link: https://www.econbiz.de/10005699264
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276